Article
Speaking genomics to parents offered germline testing for cancer predisposition: Use of a 2‐visit consent model
22 Mar 2019
Abstract excerpt
BACKGROUND: Patients with cancer are increasingly offered genomic sequencing, including germline testing for cancer predisposition or other disorders. Such testing is unfamiliar to patients and families, and clear communication is needed to introduce genomic concepts and convey risk and benefit information. METHODS: Parents of children with cancer were offered the opportunity to have their children's tumor and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
